Orphan status given to two drugs

Jersey City, NJ-The FDA has granted orphan drug designation to two investigational therapeutics of Lux Biosciences, a privately held biotechnical company specializing in treatments for ophthalmic diseases.

Related Content:

Pharmacy

Advancement in TED treatment is a bright spot

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients